JNJ
Johnson & Johnson Stock Analysis
NEW YORK STOCK EXCHANGE, INC. · Pharmaceuticals
$254.41
▼ -0.76%
Finnhub quote · as of Aug 3, 2026, 4:00 PM ET · no synthetic replacement
$254.97
Open
$257.75
High
$250.91
Low
$256.35
Prev close
$613.10B
Market cap
Analyze JNJ in depth →
Guests get 2 analyses/day. Create a free account for 5/day.
What you get with ImpliedLens
Financial statements
Income, balance sheet, cash flow from SEC filings with 30+ calculated ratios.
DCF valuation
Customizable discounted cash flow model with live inputs.
Analyst targets
Price targets, recommendation breakdowns, earnings surprises.
Institutional context
Ownership data and aggregated FINRA OTC activity.
SEC filings
Direct links to 10-K, 10-Q, 8-K, and proxy statements.
Projection models
Bull/base/bear scenario modeling with editable assumptions.
Questions to answer before investing in JNJ
01Which products and pipeline milestones drive Johnson & Johnson's next five years of cash flow?
02Which risks would invalidate the investment thesis for JNJ?
03How does JNJ's valuation compare with its growth, quality, and closest alternatives?